Ariad Pharmaceuticals Inc fka ARIA

[biotech_researcher]

Don, thanks once again for being an unbiased, critical thinker that provides actual factual information to this board.. It appears that some are shooting from the hip, and bringing over their misinformed grudges from Yahoo.

I really like this factual piece of information from the '534 trial:

Out of 12 major cytogenetic responses (MCyR) in patients with chronic phase CML, 11 remain on therapy without progression after an average of almost a year on treatment (327 days).

This kind of evidence should fully supports Harvey's position that the pivotal phase III trial for '534 will begin in the second half of 2010.